Subcutaneous Atezolizumab: A Jab Without a Benefit

Cody J. Peer, Sara M. Zimmerman, William D. Figg, Daniel A. Goldstein, Mark J. Ratain*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)134-135
Number of pages2
JournalClinical Pharmacology in Drug Development
Issue number1
StatePublished - Jan 2022
Externally publishedYes


Dive into the research topics of 'Subcutaneous Atezolizumab: A Jab Without a Benefit'. Together they form a unique fingerprint.

Cite this